<em>NT5DC2</em> is a novel prognostic marker in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma

Published:2020-07-29 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Chen Jiemin¹,Cao Jianzhong¹,Wang Penghui²,He Xiaodong¹

Affiliation:

1. Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, P.R. China

2. Department of General Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation;Biomedicine & Pharmacotherapy;2024-09

2. NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple‐negative breast cancer by blocking the EGFR pathway;Molecular Carcinogenesis;2024-01-30

3. Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients;Medicine;2023-10-06

4. Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma;Biochemical Genetics;2023-07-05

5. Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer;Medicine;2023-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP